Pages

Friday, 2 July 2021

Covaxin has overall vaccine efficacy of 78%, claims Bharat Biotech in results from Phase 3 trials

Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19. 

https://ift.tt/eA8V8J Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19.  from Zee News :India National https://ift.tt/2SHC35W

No comments:

Post a Comment